medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 03

<< Back Next >>

Ginecol Obstet Mex 2016; 84 (03)

Risk factors for fetal macrosomia in patients without gestational diabetes mellitus

García-De la Torre JI, Rodríguez- Valdez A, Delgado-Rosas A
Full text How to cite this article

Language: Spanish
References: 17
Page: 164-171
PDF size: 277.83 Kb.


Key words:

Fetal Macrosomia, Gestational diabetes mellitus, Risk factors, Obesity, Overweight.

ABSTRACT

Background: Fetal macrosomia is birth weight of 4,000 grams or more, regardless of gestational age, in Mexico representing about 5.4%. Associated with multiple demographic, physiological, metabolic and genetic factors of each population.
Objetive: Determine the risk factors associated with the development of fetal macrosomia in patients without gestational diabetes mellitus.
Methods: Retrospective, descriptive and comparative study of patients who came to delivery from January 2012 to June 2014, 88 patients, 23 patients with diagnosis of macrosomia, and 65 patients without macrosomia without gestational diabetes mellitus were included.
Results: An incidence of fetal macrosomia of 18.6%. Risk factors such as parity, history of fetal macrosomia, maternal age, maternal height more to 1.70 meters showed no difference, the percentage of overweight 105% showed 69% vs 52% on the control group and gestational diabetes screening altered that present 30.4 vs 20%.
Conclusions: Increased incidence of macrosomia was demonstrated in patients with metabolic factors such as the percentage of overweight and screening altered gestational diabetes mellitus, as they showed higher prevalence in the study group, all modifiable with preconception nutritional management and during pregnancy, to reduce initial weight and weight gain, improved fasting and postprandial blood glucose in patients with positive screening and negative tolerance curve carbohydrates to maintain fetal growth curve with in the percentiles.


REFERENCES

  1. Posada-Arévalo SE, Zavala-González MA. Prevalencia de macrosomía fetal en Cárdenas, Tabasco, Hospital General de Zona número 2. Archivos de Investigación Pediátrica de México 2007; 10(2):5-10.

  2. Barth WH. Fetal Macrosomia. ACOG. Practice Bulletin Clinical Management Guidelines for Obstetrician-gynecologists. 2013; Number 22.

  3. Ponce-Saavedra AS, González-Guerrero O, Rodríguez- García R y col. Prevalencia de macrosomía en recién nacidos y factores asociados. Revista Mexicana de Pediatría, 2011;78(4):139-142.

  4. Ávila-Reyes R, Herrera-Pen M, Salazar-Cerda CI, Camacho- Ramírez RI. Factores de riesgo del recién nacido macrosómico. Pediatría de México 2013;15(1): 6-11.

  5. Boyd ME, Usher RH, McLean FH. Fetal Macrosomia: Prediction, Risks, Proposed Management. Obstetric and Gynecology, 1983; 6(6):715-722.

  6. Ballesté-López I, Alonso-Uría RM. Factores de riesgo del recién nacido macrosómico. Rev Cubana Pediátr, 2004;76(1).

  7. Toirac-Lamarque S, Pascual-López V, Martínez-Jiménez A, Arias-Suárez RI. Macrosomía fetal en madres no diabéticas. Caracterización mínima. MEDISAN 2013;17(10):6053-6063.

  8. Landon MD, Gabbe SG. Diabetes mellitus gestacional. Obstest Gynecol, 2011;118:691-705.

  9. Gestational diabetes mellitus. Practice bulletin, No. 137. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013;122:406-16.

  10. Weight gain during pregnancy. Committee Opinion No. 548. American College of Obstretricians and Gynecologists. Obstet Gynecol 2013;121:210-2.

  11. Rhodes JC, Schoendorf KC, Parker JD. Contribution of excess weight gain during pregnancy and macrosomia to the cesarean delivery rata 1990-2000. Pediatrics 2003;111(5):1181- 5.

  12. Leikin EI, Jenkins JH, Pomerantz GA, et al. Abnormal glucose screening tests in pregnancy: a risk factor for fetal macrosomía. Obstetrics & Gynecology 1987;69(4):570-3.

  13. Voldner N, Qvigstad E, Frøslie KF, Godang K, Henriksen T, Bollerslev J. Increased risk of macrosomia among overweight women with high gestational rise in fasting glucose. J Matern Fetal Neonatal Med 2010;23(1):74-81.

  14. Arroyo P, Reynoso M, Casanueva E. Peso esperado para la talla y edad gestacional. Tablas de referencia. Ginecol Obstet Mex 1985;53:227-31.

  15. Flores-Huerta S, MartínezSalgado H. Peso al nacer de los niños y niñas derechohabientes del Instituto Mexicano del Seguro Social. Bol Med Hosp Infant Mex 2012;69(1):30-39.

  16. Nava-Díaz P, Meneses-Calderón J, Briones-Vega C, Díaz de León-Ponce M, Briones-Garduño J. Diagnóstico temprano de diabetes gestacional. Rev Asoc Mex Med Crit y Ter Int 2010;24(3):110-113.

  17. Screening and diagnosis of gestational diabetes mellitus. Committee Opinion No.504 American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;118:751-3.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2016;84